Pharmaceutical Manufacturing – Methodcarbamol Tablets

The contract involves the cGMP-compliant formulation, manufacturing, and quality control of Methodcarbamol Tablets, USP, provided in bulk tablet form. This subcontract falls under the pharmaceutical manufacturing category, specifically with NAICS code 325412, and is issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The work is to be performed at Fort Bragg, with a submission deadline for responses set on May 26, 2026. Key elements include adherence to current Good Manufacturing Practices to ensure product quality and regulatory compliance. The contract aims to supply Methodcarbamol Tablets in sufficient bulk quantities, meeting the stringent standards required for pharmaceutical applications within defense medical supply operations. Interested parties are directed to submit proposals before the deadline to participate in this essential contract supporting military medical readiness.